NCT00896454 Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium Status COMPLETED Phase PHASE2
NCT00890981 A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab Status COMPLETED Phase PHASE3
NCT00838201 Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer Status COMPLETED Phase PHASE3
NCT00680992 Study of Denosumab in Subjects With Giant Cell Tumor of Bone Status COMPLETED Phase PHASE2
NCT00680953 Denosumab Fracture Intervention Randomized Placebo Controlled Trial in Japanese Patients With Osteoporosis Status COMPLETED Phase PHASE3
NCT00556374 Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy Status COMPLETED Phase PHASE3
NCT00523341 Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis Status COMPLETED Phase PHASE3
NCT00515463 A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral Density Status COMPLETED Phase PHASE3
NCT00396279 Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone Status COMPLETED Phase PHASE2
NCT00330759 Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma. Status COMPLETED Phase PHASE3
NCT00330460 A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density. Status COMPLETED Phase PHASE3
NCT00321620 Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer Status COMPLETED Phase PHASE3
NCT00321464 A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects. Status COMPLETED Phase PHASE3
NCT00293813 A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density Status COMPLETED Phase PHASE2
NCT00286091 Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE3
NCT00259740 Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab Status COMPLETED Phase PHASE2
NCT00095498 Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT00091832 Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00089791 A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis Status COMPLETED Phase PHASE3